| abstract |
The present invention relates to a novel compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R 1 is hydrogen or fluoro and R 2 and R 3 are independently selected from hydrogen or methyl, Pharmaceutical formulations containing, use of the active compound in therapy, use for the treatment of conditions associated with glycogen synthase kinase 3 related disorders such as Alzheimer's disease, and therapeutic needs of such compounds in need of such therapy It relates to a method for treating the disorder comprising the step of administering to a mammal, including a human. [Chemical 1] |